Market Overview

Domino's Pizza Falls After Posting Mixed Q2 Earnings, Weak Sales

Domino's Pizza Falls After Posting Mixed Q2 Earnings, Weak Sales

Shares of Domino's Pizza, Inc. (NYSE: DPZ) fell sharply Tuesday morning after posting mixed second-quarter results.

What Happened

Domino's said it earned $2.19 per share in the second quarter on revenue of $811.65 million. By comparison, Street analysts expected the chain to earn $2.02 per share on revenue of $836.92 million.

Same-store sales during the quarter in the U.S. region were higher by 3%, which was short of the 4.6% expected. Similarly, international same-store sales were higher by 2.4%, shy of the 2.6% expected.

Net income for the quarter rose from $77.4 million in the same quarter last year to $92.4 million. The company attributed its higher profit to increased royalty revenues from franchised stores and higher supply chain volumes.

Domino's purchased and retired 12,295 shares of its stock and the company ended the second quarter with authorization to purchase another $147.3 million worth of shares.

Why It's Important

Despite falling short of expectations, the second quarter represents the 102nd consecutive quarter of international same-store sales growth and the 33rd consecutive quarter of U.S. growth, the company said.

"It was a good second quarter, particularly for global unit growth, as we continue to seek balanced retail sales growth through the blend of same store sales and store growth," Ritch Allison, Domino's CEO.

The stock traded lower by 7.7% to $249 per share in Tuesday's pre-market session.

Related Links:

Domino's Pizza Is Testing Autonomous Delivery Vehicles

Morgan Stanley Passes On Chipotle For Domino's

Posted-In: Pizza Ritch AllisonEarnings News Retail Sales Restaurants General Best of Benzinga


Related Articles (DPZ)

View Comments and Join the Discussion!
Fastest Market News Application
You'll Hear It First On Pro
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at

Cancer Genetics Sharply Higher After Interpace Buys Biopharma Unit

Prologis Buys Black Creek's Platform For $3.9B